MMedication Read More GLP-1 drug popularity is outpacing the science, Madison doctor says | HealthJuly 10, 2026 The Cap Times is an independent newsroom serving Madison and Wisconsin. Sign up for the Morning Update to…
MMedication Read More Why Everyone’s Turning to Minoxidil for Hair GrowthJuly 10, 2026 For one, it can prolong the hair’s growth phase. While the exact mechanism isn’t entirely understood, “it’s thought…
MMedication Read More India Tightens Rules On Alcohol-Containing Medicines: What Schedule H1 MeansJuly 10, 2026 In a significant move to curb the misuse of alcohol-containing medicinal formulations, the Central Government has amended the…
MMedication Read More Kratom explained: What it is, what it does, and why regulators are stepping in – news8000.comJuly 10, 2026 Kratom explained: What it is, what it does, and why regulators are stepping in news8000.comDEA moves to ban ‘gas…
MMedication Read More GLP-1 trials reveal diet quality gap as companion products boomJuly 10, 2026 Many GLP-1 clinical trials are not tracking what patients are consuming, pointing to a gap in the weight-loss…
MMedication Read More Why Everyone’s Turning to Minoxidil for Hair GrowthJuly 10, 2026 For one, it can prolong the hair’s growth phase. While the exact mechanism isn’t entirely understood, “it’s thought…
MMedication Read More The FDA at 120: A Long, Distinguished History Protecting AmericansJuly 9, 2026 Image By: Kyle A. Diamantas, J.D., Acting Commissioner of Food and Drugs Kyle A. Diamantas, J.D. There may…
MMedication Read More Explained: Why Nestle is tweaking flavours for people taking GLP-1 drugs | World NewsJuly 9, 2026 As the use of GLP-1 drugs is on the rise across the world, especially in the US, food…
MMedication Read More Better Growth Buy: Axsome vs Revolution MedicinesJuly 9, 2026 Axsome Therapeutics (NASDAQ: AXSM) and Revolution Medicines (NASDAQ: RVMD) have offered investors significant growth so far this year.…
MMedication Read More Ozempic Lawsuits 2026: Side Effects & $2B ClaimsJuly 9, 2026 Ozempic Lawsuits 2026: Side Effects & $2B Claims | Image by Radoslaw Maciejewski/Shutterstock A surge in demand for…
MMedication Read More Short-term savings, long-term costs: what cuts to medicines optimisation teams could mean for the NHSJuly 9, 2026 In March 2025, then health secretary Wes Streeting announced a swathe of NHS reforms. Among these was a mandate…
MMedication Read More US FDA approves kidney disease drugJuly 9, 2026 The United States Food and Drug Administration (US FDA) has approved Trutakna (atacicept-vymj), a first-in-class treatment developed by…